Drug Costs Threaten FDA Quick Approval Program, Docs Say
Drugs approved through the U.S. Food and Drug Administration's accelerated pathway often carry a high price tag, which at times leads insurers to refuse coverage of the drugs and may endanger...To view the full article, register now.
Already a subscriber? Click here to view full article